Edition:
United States

Analyst Research

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Omnicell Inc closes acquisition of UK-Based Surgichem Ltd


Monday, 25 Aug 2014 08:00am EDT 

Omnicell Inc:Announced that it has completed acquisition of Surgichem Ltd, a wholly-owned subsidiary of Bupa Care Homes (CFG) plc.Following the recent clearance by various regulatory agencies in the UK, Surgichem will be integrated with Omnicell's existing UK business, MTS Medication Technologies Ltd in coming months.MTS Medication Technologies Ltd is world's supplier of medication adherence packaging solutions. 

Company Quote

35.37
-0.15 -0.42%
22 Jul 2016